Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cancer Registry of Norway Resource Report Resource Website 1+ mentions |
Cancer Registry of Norway (RRID:SCR_008879) | Cancer Registry of Norway | institution | Comprises 3 registries of cancer patients in Norway: the Incidence Registry, the Clinical Registry and Cancer Statistics. The Incidence Registry contains the basic data items collected from clinicians and pathologists, as well as from administrative discharge and mortality sources. It is updated continuously with information on both new cases, as well as cases diagnosed in previous years. All medical doctors in the country are instructed by law to notify new cancer cases. Clinical Registries: Registration of treatment and follow-up of Norwegian cancer patients. Clinical registries comprehensive registration schemes dedicated to specific cancers have been established to include detailed information on diagnostic measures, therapy, and follow-up. Cancer Statistics: Database of cancer statistics. The Cancer Registry of Norway is maintained by the Institute of Population-based Cancer Research and established in 1951. It is one of the oldest national cancer registries in the world. This, combined with the unique personal identification number used in Norway, makes the Cancer Registry''s data suitable, also internationally; by establishing new knowledge through research and spreading information on cancer. | is parent organization of: Janus Serum Bank | Cancer, Breast cancer, Cervical cancer, Colorectal cancer, Prostate cancer, Lung cancer, Hereditary cancer, Pediatric solid tumor, Ovarian cancer, Malignant melanoma | grid.418941.1, ISNI: 0000 0001 0727 140X, nlx_149447 | https://ror.org/03sm1ej59 | SCR_008879 | Cancer Registry of Norway: Institute of Population-based Cancer Research | 2026-07-25 12:06:56 | 6 | |||||||
|
Mario Negri Institute for Pharmacological Research; Milan; Italy Resource Report Resource Website |
Mario Negri Institute for Pharmacological Research; Milan; Italy (RRID:SCR_011361) | Mario Negri Institute | institution | A not-for-profit biomedical research institute whose main aim is to help defend human health and life. Research programs span from the molecular level to the whole human being, and the findings help build up the basis for developing new drugs, and making existing ones more effective. The main research headings are the battle against cancer, nervous and mental illnesses, cardiovascular and kidney diseases, rare diseases and the toxic effects of environmental contaminants, mother and child''''s health. The Institute is also involved in research on pain relief and drug addiction. Parallel to its biomedical investigations, the Mario Negri Institute runs training schemes for laboratory technicians and graduate researchers. It takes part in a range of initiatives to communicate information in biomedicine, on a general level and with the specific aims of improving health care practice, and encouraging more rational use of drugs. There are also research units in Bergamo, at Ranica - near Bergamo - and at Santa Maria Imbaro, near Chieti. | is related to: PharmaCog | Cancer, Nervous illness, Mental illnesses, Cardiovascular disease, Kidney disease, Rare disease, Environmental contaminant toxicity | nlx_158317 | SCR_011361 | Mario Negri Institute for Pharmacological Research, Istituto di Ricerche Farmacologiche Mario Negri, Mario Negri Istituto di Ricerche Farmacologiche | 2026-07-25 12:07:17 | 0 | ||||||||
|
Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka; Japan Resource Report Resource Website |
Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka; Japan (RRID:SCR_011477) | OMCCCD | institution | Center for cancer and cardiovascular diseases with a focus on advanced cancer therapy in the Kansai area. It consists of the Hospital, the Research Institute, and the Department of Cancer Control and Statistics. The Research Institute is responsible for acquiring and applying knowledge of the molecular and genetic aspects of human cancer. The mission of the Research Institute is to perform basic and applied cancer research through collaboration with the Hospital and the Department of Cancer Control and Statistics. The large tumor tissue collection is the major focus of their research efforts. The Research Institute includes seven official departments: Biology, Biochemistry, Pathology, Molecular Medicine & Pathophysiology, Molecular Biology, Molecular Genetics, and Immunology. In addition, a group conducted by the Director (Director''s Unit) and Laboratory of Genome Informatics. The research objectives are as follows. # Clinical research. ## Prognosis predictor of gliomas based on gene expression profiling ## Targeted oncolytic virus # Technical developments for cancer research ## A new method for storing cancer cells taken from human tumor tissues (cancer tissue-originated spheroid) ## Bioinformatics for personalized genomics # Basic research ## Mechanism of metastasis ## Low oxygen environment and cancer ## Structure analysis of oligosaccharide on human cancer cells ## Proof-of-principle study of artificial adjuvants | is parent organization of: Brain Gene Expression Database | Cancer, Cardiovascular disease | nlx_66393 | SCR_011477 | 2026-07-25 12:07:15 | 0 | |||||||||
|
German Cancer Research Center Resource Report Resource Website 1+ mentions |
German Cancer Research Center (RRID:SCR_012942) | DKFZ | institution | Biomedical research institute in Germany that investigates the mechanisms of cancer and works to identify cancer risk factors. They provide the foundations for developing novel approaches in the prevention, diagnosis, and treatment of cancer and are a member of the Helmholtz Association of National Research Centers. Professor Harald zur Hausen was awarded the Nobel Prize for Medicine for his outstanding scientific contribution to the study of human papillomaviruses (HPV). In addition, the staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. The Center is funded by the German Federal Ministry of Education and Research (90%) and the State of Baden-Württemberg (10%). |
is related to: Helmholtz Center Munich is related to: MIP-DILI is parent organization of: AutoPrime is parent organization of: Axel Database is parent organization of: glycomedb is parent organization of: MITK Diffusion is parent organization of: LifeDB is parent organization of: LipOXygenases DataBase is parent organization of: Diffusion MRI - In-vivo and Phantom Data is parent organization of: Diffusion MRI at DKFZ Heidelberg is parent organization of: DKFZ Genomics and Proteomics Core Facility is parent organization of: German Cancer Research Center Labs and Facilities is parent organization of: GenomeRNAi is parent organization of: Division of Molecular Genome Analysis is parent organization of: LiGraph is parent organization of: pdb-data is parent organization of: GENSCAN is parent organization of: DKFZ Small Animal Imaging Core Facility |
Cancer | grid.7497.d, Wikidata: Q449325, ISNI: 0000 0004 0492 0584, nlx_36666, Crossref funder ID: 100008658 | https://ror.org/04cdgtt98 | SCR_012942 | Deutsches Krebsforschungszentrum | 2026-07-25 12:07:40 | 7 | |||||||
|
Genome Alteration Print Resource Report Resource Website 1+ mentions |
Genome Alteration Print (RRID:SCR_012016) | GAP | software resource | Software for automatic detection of absolute segmental copy numbers and genotype status in complex cancer genome profiles measured by single-nucleotide polymorphism (SNP) arrays. The method is based on pattern recognition of segmented and smoothed copy number and allelic imbalance profiles. The method performs well even for poor-quality data, low tumor content, and highly rearranged tumor genomes. | genome, segmental copy number, genotype, genome profile, copy number, single-nucleotide polymorphism, array |
is listed by: OMICtools has parent organization: Curie Institute; Paris; France |
Cancer, Tumor | PMID:19903341 | OMICS_02119 | SCR_012016 | Genome Alteration Print (GAP): Mining complex cancer genomic profiles | 2026-07-25 12:07:29 | 4 | ||||||
|
UCL Biobank Resource Report Resource Website |
UCL Biobank (RRID:SCR_000517) | UCL Biobank | biomaterial supply resource, material resource | Two University College London (UCL) biobanks, one based at the Royal Free Hospital (RFH) Campus and the other based at Bloomsbury supporting Pathology and the Cancer Institute, will act as physical repositories for collections of biological samples and data from patients consented at UCLH, Partners Hospitals and external sources. This will incorporate collections of existing stored samples and new collections. UCL-RFH BioBank, the physical repository at the Royal Free, presents a unique opportunity to advance medical research through making access to research tissue easier, faster and much more efficient. The BioBank is both a physical repository, with capacity for up to 1 million cryogenically stored samples and a virtual repository for all tissue, cell, plasma, serum, DNA and RNA samples stored throughout UCLP. In particular, samples considered "relevant material", such as tissues and cells, that are licensed by the Human Tissue Authority, can be stored long term. Existing holdings of tissues and cells where appropriate can be transferred to the Physical BioBank at the Royal Free. UCL - Royal Free BioBank provides a flexible approach to banking, allowing the Depositor to pick and choose services that are tailored to fit their requirements. Collaborations arising from publicizing of the existence of the holdings are entirely at the discretion of the depositor, as the facility ensures that access to the deposits remains at the decision of the Depositor/User. UCL Biobank for studying Health and Disease (based at Pathology-Rockefeller building and the UCL-Cancer Institute will support projects principally involved in the study of human disease. The aim is to support primarily, research in the Pathology Department, UCLH and the UCL-Cancer Institute but it will also support other UCLH partners. The biobank will store normal and pathological specimens, surplus to diagnostic requirements, from relevant tissues and bodily fluids. Stored tissues will include; snap-frozen or cryopreserved tissue, formalin-fixed tissue, paraffin-embedded tissues, and slides prepared for histological examination. Tissues will include resection specimens obtained surgically or by needle core biopsy. Bodily fluids will include; whole blood, serum, plasma, urine, cerebrospinal fluid, milk, saliva and buccal smears and cytological specimens such as sputum and cervical smears. Fine needle aspirates obtained from tissues and bodily cavities (e.g. pleura and peritoneum) will also be collected. Where appropriate the biobank will also store separated cells, protein, DNA and RNA isolated from collected tissues and bodily fluids described above. Some of the tissue and aspirated samples will be stored in the diagnostic archive. | tissue, cell, plasma, serum, dna, rna, blood, serum, plasma, urine, cerebral spinal fluid, milk, saliva, buccal smear, sputum, cervical smear, pleura, peritoneum, protein, body fluid, cryopreserved, frozen, snap-frozen, formalin-fixed, paraffin-embedded, slide, cancer, disease, normal |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University College London; London; United Kingdom |
Cancer, Disease, Normal | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_36620 | SCR_000517 | Biobanking at UCL | 2026-07-25 12:12:18 | 0 | ||||||
|
The Cancer Genome Atlas Resource Report Resource Website 5000+ mentions |
The Cancer Genome Atlas (RRID:SCR_003193) | TCGA | biomaterial supply resource, material resource | Project exploring the spectrum of genomic changes involved in more than 20 types of human cancer that provides a platform for researchers to search, download, and analyze data sets generated. As a pilot project it confirmed that an atlas of changes could be created for specific cancer types. It also showed that a national network of research and technology teams working on distinct but related projects could pool the results of their efforts, create an economy of scale and develop an infrastructure for making the data publicly accessible. Its success committed resources to collect and characterize more than 20 additional tumor types. Components of the TCGA Research Network: * Biospecimen Core Resource (BCR); Tissue samples are carefully cataloged, processed, checked for quality and stored, complete with important medical information about the patient. * Genome Characterization Centers (GCCs); Several technologies will be used to analyze genomic changes involved in cancer. The genomic changes that are identified will be further studied by the Genome Sequencing Centers. * Genome Sequencing Centers (GSCs); High-throughput Genome Sequencing Centers will identify the changes in DNA sequences that are associated with specific types of cancer. * Proteome Characterization Centers (PCCs); The centers, a component of NCI's Clinical Proteomic Tumor Analysis Consortium, will ascertain and analyze the total proteomic content of a subset of TCGA samples. * Data Coordinating Center (DCC); The information that is generated by TCGA will be centrally managed at the DCC and entered into the TCGA Data Portal and Cancer Genomics Hub as it becomes available. Centralization of data facilitates data transfer between the network and the research community, and makes data analysis more efficient. The DCC manages the TCGA Data Portal. * Cancer Genomics Hub (CGHub); Lower level sequence data will be deposited into a secure repository. This database stores cancer genome sequences and alignments. * Genome Data Analysis Centers (GDACs) - Immense amounts of data from array and second-generation sequencing technologies must be integrated across thousands of samples. These centers will provide novel informatics tools to the entire research community to facilitate broader use of TCGA data. TCGA is actively developing a network of collaborators who are able to provide samples that are collected retrospectively (tissues that had already been collected and stored) or prospectively (tissues that will be collected in the future). | genome, genome sequencing, breast, central nervous system, endocrine, gastrointestinal, gynecologic, head, neck, hematologic, skin, soft tissue, thoracic, urologic, clinical, genomic characterization, analysis, tumor genome, demographic, gene expression, copy number alteration, epigenetic, dna sequence, exome, snp, methylation, mrna, mirna, FASEB list |
is used by: Mutation Annotation and Genomic Interpretation is used by: BioXpress is used by: cancerRxTissue is listed by: One Mind Biospecimen Bank Listing is related to: Cancer3D is related to: Cancer Research Data Commons is related to: CancerMIRNome is related to: Broad Institute Genomics Platform has parent organization: National Cancer Institute works with: FireBrowse |
Cancer, Tumor, Normal, Breast cancer, Central Nervous System cancer, Endocrine cancer, Gastrointestinal cancer, Gynecologic cancer, Head cancer, Neck cancer, Hematologic cancer, Skin cancer, Soft tissue cancer, Thoracic cancer, Urologic cancer | NCI 261200800001E-12-0-1 | nlx_156913 | SCR_003193 | Cancer Genome Atlas | 2026-07-25 12:12:27 | 6292 | ||||||
|
Pleiades Promoter Project: Genomic Resources Advancing Therapies for Brain Disorders Resource Report Resource Website 1+ mentions |
Pleiades Promoter Project: Genomic Resources Advancing Therapies for Brain Disorders (RRID:SCR_003282) | Pleiades Promoter Project | biomaterial supply resource, material resource | Project to generate human DNA promoters of less than 4 kb (MiniPromoters) to drive gene expression in defined brain regions of therapeutic interest for diseases such as Alzheimer, Parkinson, Huntington, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Spinocerebellar Ataxia, Depression, Autism, and Cancer. Project develops and shares tools like human MiniPromoters that drive region- and cell-specific gene expression in the mouse brain, expression constructs, mouse embryonic stem cell lines, and knock-in mice all of which carry brain-specific MiniPromoters. Project is daughter of Genome Canada Project, Atlas of Gene Expression in Mouse Development, within which mouse brain gene expression data have already been gathered. Project team has collaborated with International BioPharma Solutions Ltd., management and communications consulting company specializing in product development and commercialization advice. Project will explore challenging interface between science and journalism with focus on genomics and gene therapy. | Human, DNA, promoter, gene, expression, brain, disorder, therapy |
is listed by: One Mind Biospecimen Bank Listing is related to: CanEuCre is related to: JAX Cre Repository is related to: Recombinase (cre) Activity has parent organization: University of British Columbia; British Columbia; Canada |
Alzheimer, Parkinson, Huntington, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Spinocerebellar Ataxia, Depression, Autism, Cancer | Genome Canada ; Genome British Columbia ; UBC Institute of Mental Health ; Child and Family Research Institute |
Free, Freely available | nif-0000-01868 | https://plone.bcgsc.ca/project/pleiades-promoter-project | http://www.pleiades.org/ | SCR_003282 | 2026-07-25 12:12:27 | 4 | ||||
|
Karolisnka Biobank Resource Report Resource Website |
Karolisnka Biobank (RRID:SCR_004355) | KI Biobank | biomaterial supply resource, material resource | KI Biobank is an accredited core facility offering sample collection services. KI Biobank is located at the Department of Medical Epidemiology and Biostatistics. KI Biobank offer infrastructure for pre analytical sample handling and provide researchers guidance on how samples should be taken and labeled. The processes comprise registration, handling, storage and distribution of samples. KI Biobank also offers DNA-extraction from blood and saliva. In order to insure complete traceability on samples and belonging information all processes are controlled by a Laboratory Information Management System (LIMS). For every new study a contract is established describing the study and the disposition rights. We also help in writing Biobank agreements including multicenteravtal and Material Transfer Agreement. KI Biobank is, according to the Biobank law, responsible for all sample collections handled within the core facility and those that are stored on the departments on KI campus. Clinical sample collections are handled by the Biobank units at the respective hospitals within the Stockholm County Council. Besides the samples that are stored centrally at KI Biobank, KI Biobank is also the administrative biobank for research sample collections at Karolinska Institutet that are stored and administrated at the departments. All research sample collections must be reported to KI Biobank. The following types of sample collections are registered in the biobank; sample collections taken within the regular health care that has been transferred to Karolinska Institutet with an agreement of transfer, samples taken from healthy individuals or other persons out of the regular health care and samples that have been taken abroad. | asthma, lung disease, cancer, cardiac disease, multiple sclerosis, ms, neurological disease, neurological injury, psychiatric disease, twin, dna-extraction |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Karolinska Institute; Stockholm; Sweden is parent organization of: KI Biobank - Amphetamine dependence is parent organization of: KI Biobank - PAIN is parent organization of: PRACSIS - Prognosis and Risk in Acute Coronary Syndromes In Sweden is parent organization of: KI Biobank is parent organization of: KI Biobank - KOL is parent organization of: KI Biobank - SCI is parent organization of: KI Biobank - GEMS is parent organization of: KI Biobank - TBI is parent organization of: KI Biobank - EIMS is parent organization of: KI Biobank - IMSE is parent organization of: KI Biobank - BROAD is parent organization of: KI Biobank - SBP is parent organization of: KI Biobank STAGE-ADHD is parent organization of: KI Biobank - STANLEY is parent organization of: KI Biobank - STAR is parent organization of: KI Biobank - EuroClot is parent organization of: KI Biobank - Economical Behavior is parent organization of: CATSS - Child and Adolescent Twin Study in Sweden is parent organization of: KI Biobank - SATSA is parent organization of: KI Biobank - SALTY is parent organization of: KI Biobank - STAGE is parent organization of: KI Biobank - TwinGene is parent organization of: BIOAIR - BIOmarkers in severe Chronic AIRway Disease is parent organization of: KI Biobank - NOAK is parent organization of: OLIN - Obstructive Lung disease in Northern Sweden is parent organization of: Cancer of the Prostate in Sweden (CAPS) is parent organization of: KI Biobank - CEFALO is parent organization of: ICAP - Integrated analysis of prostate cancer is parent organization of: LIBRO-1: Individualized prediction and prevention of breast cancer is parent organization of: KI Biobank - PROCAP is parent organization of: SCALE - Scandinavian lymphoma etiology is parent organization of: SPSAC - Stockholm PSA Cohort is parent organization of: KI Biobank - Tissue Biobank is parent organization of: KI Biobank - CEFAM is parent organization of: KI Biobank - PAROKRANK is parent organization of: KI Biobank - Sodertaljehjartan is parent organization of: KI Biobank - Parkinson is parent organization of: KI Biobank - EXT is parent organization of: KI Biobank - ALF is parent organization of: KI Biobank - HARMONY is parent organization of: Twin Study of Child and Adolescent Development - TCHAD is parent organization of: SHEEP - Stockholm Heart Epidemiology Program |
Asthma, Lung disease, Cancer, Cardiac disease, Multiple Sclerosis, Neurological disease, Neurological injury, Mental disease, Healthy, Normal control, Twin, Late adult human | nlx_37545 | http://ki.se/ki/jsp/polopoly.jsp?d=9620&l=en | SCR_004355 | Karolinska Institutet Biobank | 2026-07-25 12:12:31 | 0 | ||||||
|
Swedish Regional Biobank Resource Report Resource Website |
Swedish Regional Biobank (RRID:SCR_004503) | Swedish RBC | biomaterial supply resource, material resource | To meet the law requirements and regulations of the National Board of the Southern Health Care Region, Region Skane and Lund University agreed to establish a common biobanking center for Southern healthcare region. Regional biobanksrcentrum will develop and maintain systems for quality assurance and integrity protected using biobanks. The Regional Biobank center is responsible for matters relating to the collection, storage and use of samples stored in biobanks in the Southern healthcare region. Regional Biobank center operations consist of: * to promote the use of biobank material is in accordance with legal requirements biobank * to promote integrity protected and safe storage of repository material * to provide information about the biobank law and biobank materials used for individual sample donors, health professionals, researchers and the public * to handle requests for modified consent and desire to destroy or de test * maintaining a current and privacy protected records of repository material in the region * work to the individual''s integrity will be strengthened in relation to research on biobank material. Tissue samples available to other parties, by surrendering, or by sending tissue samples for analysis, requiring the return or destruction, after completion of the analysis. Regional Biobank Centre (RBC) for the southern healthcare region was established in 2004 and was until 2010 in the Oncology Centre. As of January 1, 2011 it is under the management of RBC Labmedicin Skane. | tissue, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Lund University; Lund; Sweden |
Cancer, Birth defect, Chromosomal abnormality | Application forms should be used by researchers who want access to samples from health care research. The form contains two parts: I. Application for establishment of and access to samples. II. Agreement on release of samples and personal data. | nlx_48758 | SCR_004503 | Swedish Regional Biobank Center Southern Health Care Region, Swedish Regional Biobank Center, Regional Biobank Centre Southern Health Care Region, RBC Southern Health Care Region | 2026-07-25 12:12:30 | 0 | ||||||
|
Janus Serum Bank Resource Report Resource Website 1+ mentions |
Janus Serum Bank (RRID:SCR_005885) | Janus Serum Bank | biomaterial supply resource, material resource | The Janus Serum Bank has blood samles from 317 000 Norwegians. The biobank is reserved for cancer research, and is internationally unique regarding size and number of cancer cases. The Janus Serum Bank is a population based biobank reserved for cancer research. The specimens are collected during the period from 1972-2004 and are stored at 25 degrees Celsius. The samples originate from 317 000 persons in Norway who have participated in health studies and also from blood donors in and around Oslo. Today, samples are only collected from earlier donors in the Janus Serum Bank who have developed cancer. The Bank is internationally unique regarding size and number of cancer cases. Annual linkage to the Cancer Registry shows that 52 500 donors are diagnosed with cancer as of December 31, 2009. The main goals of the biobank are to make the material available to cancer researchers over the whole world and deliver quality assured samples and data. The Janus Serum Bank is registered in the Biobank Register (Notification number 737) | blood, cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Cancer Registry of Norway |
Cancer | Public: The main goals of the biobank are to make the material available to cancer researchers over the whole world and deliver quality assured samples and data. | nlx_149448 | SCR_005885 | Janus serumbank | 2026-07-25 12:12:34 | 1 | ||||||
|
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology Resource Report Resource Website |
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology (RRID:SCR_005957) | Biobanks of the Department of Clinical Pathology and Cytology | instrument supplier, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 6th, 2022. The biobank comprises paraffin blocks of surgical and autopsy tissue samples and corresponding histological slides as well as cytological material consisting of slides of vaginal smears, fine needle aspiration biopsies and exfoliative cytological material. The tissue samples date back until 1944 and most of the cytological samples until 1970. A subunit of the bank constitutes the National Tissue Microarray Centre. This center is supported by SWEGENE with the purpose to organize and construct tissue microarrays (TMA:s) for high throughput molecular pathology research on various kinds of tumors and other diseases. By linking the TMA.s to long-term and complete clinical follow-up data, prognostic and predictive studies will be facilitated. Biobank content: * Approximately 2,4 million paraffin blocks of surgical tissue specimens, * 1,1 million paraffin blocks of tissue samples from autopsies, * 3,8 million histological slides and * 1,6 million cytology slides. At present, the Tissue Microarray Centre includes: * A consecutive series of all invasive breast cancers (n=600) diagnosed in Malmo between 1988 and 1992. * All incident breast cancers within the Malmo Diet and Cancer cohort (n=400). * A subgroup of 600 pre-menopausal primary breast cancers within the nationwide, population-based randomized tamoxifen trial SBII:2. * 180 primary breast cancers from post-menopausal women included in a similar study. * A set of 120 extremely well characterized primary breast cancer samples with a clinical follow-up of 10 years. More than 40 relevant tumor biological parameters have been recorded in this material and it is therefore useful for a first screening of a marker in order to identify associations to other gene products. * 350 renal cell carcinomas (In collaboration with NUS). We provide researchers with state-of-the-art population based tissue microarrays with long-term and complete follow-up data on survival and treatment. With the TMA-technology, valuable biobank material will be preserved, allowing high throughput in-situ analyses of various tumors and other diseases with a minimal waste of tissue. | surgery, autopsy, histology slide, vaginal smear, fine needle aspiration, biopsy, tissue microarray, tumor, disease, cancer, diet, renal cell, kidney |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Swedish National Biobank Program |
Breast cancer, Cancer, Tumor, Carcinoma | SWEGENE | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_151315 | SCR_005957 | UMAS University Hospital - Biobanks of the Department of Clinical Pathology Cytology | 2026-07-25 12:13:25 | 0 | |||||
|
UK DNA Banking Network Resource Report Resource Website 1+ mentions |
UK DNA Banking Network (RRID:SCR_010619) | UDBN | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented on October 6, 2011. A project to collect, store and study DNA samples from tens of thousands of healthy volunteers and patients with diseases of major public importance. It aims to identify genes that are risk factors for the conditions. The network consists of 13 collections led by different clinicians throughout the UK. At its heart is an archive infrastructure which manages the DNA and the information associated with it. The European Collection of Cell Cultures in Porton Down handles the blood, peripheral blood lymphocytes and EBV-transformed cell lines, while the Centre for Integrated Genomic Medical Research at Manchester University manages the DNA. These banked samples are available to UK and international researchers, who can examine data and set up collaborative work by registering at the DNA Network's website. The conditions for which samples are currently collected and stored are: Acute leukemia, Asthma and eczema, Late onset Alzheimer's disease, Breast cancer, Colorectal cancer, Coronary artery disease, Glomerulonephritis, Hypertension, Age-related macular degeneration, Multiple sclerosis, Parkinson's disease, Type 2 diabetes, Unipolar depression. | alzheimer, gene, dna, peripheral blood lymphocyte, ebv-transformed cell line |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Manchester; Manchester; United Kingdom |
Leukemia, Asthma, Eczema, Alzheimer's disease, Breast cancer, Colorectal cancer, Coronary artery disease, Glomerulonephritis, Hypertension, Age-related macular degeneration, Multiple Sclerosis, Parkinson's disease, Type 2 diabetes, Unipolar depression, Cancer | MRC | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_60877 | SCR_010619 | 2026-07-25 12:12:55 | 3 | ||||||
|
Biological Resource Centre - National Institute for Cancer Research Resource Report Resource Website 1+ mentions |
Biological Resource Centre - National Institute for Cancer Research (RRID:SCR_010548) | CRB-IST | biomaterial supply resource, material resource | The Centro di Risorse Biologiche (CRB-IST), institutional facility of IST, has been recently established by the General Director (Deliberation number 624 July 11, 2008). It aims at co-ordinating already existing biobanking activities, and participating in the European Infrastructure of Biobanks and Biomolecular Resources (BBMRI), in preparation in the frame of the 7th FP of the European Community. Aims: * to facilitate high quality translational research dependent on biological material and data * to address ethical issues on biobanking * to promote the project at the population level * to co-ordinate the IST biobanks and cell banks * to harmonize technical and management SOPs, according to international best practices * to help reduce costs for collection and storage of biological material * to favor institutional recognition at a regional, national and international level - to sustain the role of the Institute in the European infrastructure. | cancer, serum, plasma, frozen, formalin-fixed paraffin-embedded |
is listed by: One Mind Biospecimen Bank Listing is related to: Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) has parent organization: IST National Institute for Cancer Research; Genoa; Italy |
Cancer | Public | nlx_31955 | SCR_010548 | Centro di Risorse Biologiche - istituto nazionale per la ricerca sul cancro, Centro di Risorse Biologiche - IST | 2026-07-25 12:12:52 | 5 | ||||||
|
Cancer Control using Population-based Registries and Biobanks Resource Report Resource Website |
Cancer Control using Population-based Registries and Biobanks (RRID:SCR_004902) | CCPRB | biomaterial supply resource, material resource | CCPRB (Cancer Control using Population-based Registries and Biobanks) is a Network of Excellence project within the sixth framework programme of the European Union. It is aiming at improved control of cancer by facilitating research linking biobanks and cancer registries. The project involves a systematic quality assurance and continuous development of standards and norms for human sample biobanks in Europe, as well as development of improved integrity-protection standards in the handling of sensitive information in connection with biobank-based research. The samples in the biobanks will be used in large-scale cancer research searching for genetic and infectious causes to cancer, in particular in the areas of breast and colorectal cancer and childhood leukemia. Project objectives: * Provide the study base for uniquely large population-based prospective studies on cancer * Define and implement a generally applicable European Quality Standard for Biobanking that will include improved data and specimen standardization, acquisition and analysis, reliable and standardized statistical analysis as well as improved management and co-ordination of European biobanks. * Define and promote the implementation of integrity-proof methods for biobank-based research involving well defined and secure third party code-keeping systems. * Enable large-scale, population-based research on: ** evaluation of cancer treatment and role of molecular markers in treatment selection ** use over-generation registry linkages applied to large biobank cohorts to identify and evaluate genetic predisposition associated with increased cancer risk as well as interactions with common environmental exposures. ** use over-generation registry linkages applied to large biobank cohorts to explore and evaluate intrauterine exposures associated with increased cancer risk ** exploit the power of large population cohorts for design of optimal strategies for cancer prevention and its evaluation. * Establish a Europe-wide network for spreading the awareness of i) the data, samples and knowledge generated European biobank-based research ii) possibilities for future biobank-based research and iii) the best practice quality standards for biobank-based research. | genetic, infectious disease, young human, child, registry, biobank |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Lund University; Lund; Sweden |
Cancer, Breast cancer, Colorectal cancer, Childhood leukemia, Leukemia | European Union FP6 | nlx_87258 | SCR_004902 | CCPRB (Cancer Control using Population-based Registries and Biobanks), Cancer Control using Population-based Registries Biobanks, CCPRB (Cancer Control using Population-based Registries Biobanks), CCPRB - Cancer Control using Population-based Registries and Biobanks | 2026-07-25 12:12:32 | 0 | ||||||
|
Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource Resource Report Resource Website 1+ mentions |
Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource (RRID:SCR_004626) | HCC Tissue Biorepository | cell repository, biomaterial supply resource, material resource | The Hollings Cancer Center Tissue Biorepository & Research Pathology Services Shared Resource provides investigators with a centralized infrastructure that promotes biomedical research involving the use and study of human biospecimens. The shared resource is comprised of four integrated components: Biospecimens and data bank, Laser Capture Microdissection, Tissue Microarray, and Research Pathology Services. These components, along with extensive staff expertise, offer a comprehensive means by which researchers can utilize valuable human biospecimens and cutting edge technology to support basic, translational and clinical research. Services: * Biospecimen and Data Bank ** Collecting, processing, and banking of tissue, saliva, urine, blood, plasma, serum, and other tissue derivatives; including those for protocol driven studies ** Retrieval of banked specimens linked to clinicopathologic data, while maintaining patient confidentiality, for research use ** Quality control of collected tissue by the Tissue Biorepository Director, a trained pathologist: verification of diseased state and assessment of tumor purity, etc ** Quality control of DNA/RNA/protein isolated from collected tissue using the Agilent Bioanalyzer * Laser Capture Microdissection ** Identification, localization, and microdissection of targeted cell populations (from human and animal tissue sources) ** Extraction of DNA/RNA/protein from microdissected samples. ** Quality analysis and quality control of isolated nucleic acid using Agilent Bioanalyzer * Tissue Microarray ** Create custom and standard TMAs ** Consultation and technical support in the construction and analyses of TMA * Research Pathology Services ** Macrodissection of tissue prior to isolation of DNA/RNA/protein to increase tumor purity ** Immunohistochemistry and In-situ hybridization ** Quantitative image analysis on conventional and TMA sections, including tissue scoring, Ki-67 labeling index, microvascular density counting, and tissue microarray scoring, etc. * Bio-molecular Assessment ** Cellular DNA, RNA and protein prepared by the Tissue Repository from banked specimens or any other biomolecules submitted by investigators can be qualitatively assessed by Agilent Bioanalyzer, prior to use for downstream applications such as microarray and/or qRT-PCR analysis | cancer, leukemia, lymphoma, myeloma, solid tumor, tumor, tissue, saliva, urine, blood, plasma, serum, dna, rna, protein, clinicopathologic data, immunohistochemistry, in-situ hybridization, macrodissection, tissue microarray, paraffin, frozen, oct embedded, block, h & e staining, slide, malignant, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical University of South Carolina; South Carolina; USA |
Cancer, Leukemia, Lymphoma, Myeloma, Solid tumor, Tumor | Public: Prices listed for HCC, MUSC, And outside MUSC. | nlx_62775 | http://hcc.musc.edu/research/sharedresources/biorepository/index.htm | SCR_004626 | Hollings Cancer Center Tissue Biorepository Research Pathology Services Shared Resource | 2026-07-27 09:32:05 | 2 | |||||
|
JP McCarthy Cord Stem Cell Bank Resource Report Resource Website |
JP McCarthy Cord Stem Cell Bank (RRID:SCR_004540) | J.P. McCarthy Cord Stem Cell Bank | cell repository, biomaterial supply resource, material resource | The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute is a public, non-profit stem cell bank with over 1,200 umbilical cord blood units in its inventory. The bank was founded in 2001 and is one of only 21 internationally recognized cord stem cell banks affiliated with the National Marrow Donor Program. The only bank of its kind in Michigan, it was created in anticipation of providing life-saving hope to people who have been diagnosed with cancer and serious blood disorders. Karmanos collects, processes and stores donated umbilical cord blood that becomes a readily available source of hematopoietic stem cells for transplant in children and adults with leukemia, lymphoma, sickle cell disease or other life-threatening conditions. The J.P. McCarthy Cord Blood Bank and Carls Processing Laboratory is also accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The accreditation signifies the highest standards of practice in collection, processing and transplantation. Karmanos is the only FACT accredited cord blood bank in Michigan and one of only nine in the United States. In the Detroit Metropolitan area, the number of hospitals participating in the collection of cord blood is rapidly increasing. Please consider donating your baby''s cord blood if you are delivering at one of our participating hospitals: Henry Ford Wyandotte Hospital in Wyandotte, MI, Providence Park Hospital in Novi, MI, St. Joseph Mercy Hospital in Ann Arbor | stem cell |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Karmanos Cancer Institute |
Cancer, Blood disorder, Leukemia, Lymphoma, Sickle cell disease, Life-threatening condition | J.P. McCarthy Fund ; Carls Foundation |
nlx_53223 | http://www.karmanos.org/app.asp?id=1142 | SCR_004540 | J.P. McCarthy Cord Stem Cell Bank | 2026-07-27 09:32:03 | 0 | |||||
|
Oncotator Resource Report Resource Website 100+ mentions |
Oncotator (RRID:SCR_005183) | Oncotator | analysis service resource, service resource, data analysis service, production service resource | A tool for annotating human genomic point mutations and indels with data relevant to cancer researchers. Genomic Annotations, Protein Annotations, and Cancer Annotations are aggregated from many resources. A standalone version of Oncotator is being developed. | annotate, genomic, point mutation, indel, mutation, genome, protein, variant |
is listed by: OMICtools has parent organization: Broad Institute |
Cancer | OMICS_00178 | SCR_005183 | 2026-07-27 09:32:13 | 215 | ||||||||
|
CanPredict Resource Report Resource Website 1+ mentions |
CanPredict (RRID:SCR_008216) | CanPredict | analysis service resource, service resource, data analysis service, production service resource | Web application that uses a combination of computational methods to identify those changes most likely to be cancer-associated. |
is listed by: OMICtools has parent organization: University of California at San Francisco; California; USA |
Cancer | OMICS_00142 | SCR_008216 | CanPredict: A computational tool for predicting Cancer-associated mutations | 2026-07-27 09:33:01 | 3 | ||||||||
|
GSE27831 Resource Report Resource Website 10+ mentions |
GSE27831 (RRID:SCR_003646) | data or information resource, data set | Curated data set from gene expression profiles of 29 unique samples from uveal melanoma patients that were measured on Affymetrix microarray. In addition, expression of syntenin-1 was measured by RT-PCR and this data is also available in the study. | syntenin-1, gene expression profile, gene expression, eye, adult human |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Uveal melanoma | Free, Public | nlx_157798 | SCR_003646 | 2026-07-27 09:31:49 | 12 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the nidm-terms Resources search. From here you can search through a compilation of resources used by nidm-terms and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that nidm-terms has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on nidm-terms then you can log in from here to get additional features in nidm-terms such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into nidm-terms you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
